ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNR vs TLSI // DIVIDEND YIELD & FCF PAYOUT SAFETY

Burning Rock Biotech Limited (NASDAQ) VS. TriSalus Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: BNR 4 — TLSI 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNR VS. TLSI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNR TLSI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 74.70% 84.60% -9.90 TLSI /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.14% -7.96% +3.82 BNR /fcf-yield <GO>
Operating Margin -10.20% -59.70% +49.50 BNR /operating-margins <GO>
Net Profit Margin -10.30% -60.00% +49.70 BNR /net-margins <GO>
Revenue Growth (YoY) 9.20% 53.40% -44.20 TLSI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 BNR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.1 44.9 -5.80 TLSI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $116.5M $237.7M -$121.1M TLSI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNR REV TLSI REV BNR GROSS % TLSI GROSS % BNR FCF TLSI FCF
FY 2025 $77.2M $45.2M 74.7% 84.6% -$4.8M -$18.9M
FY 2024 $70.7M $29.4M 70.3% 86.1% -$13.4M -$41.2M
FY 2023 $75.7M $18.5M — — -$36.0M -$50.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNR // BETA —
TLSI // BETA —